
Chemoimmunotherapy Shows Promise in Young SCLC
In a groundbreaking multicenter retrospective study published in BMC Cancer, researchers have delved into the crucial question of how young patients with extensive-stage small cell lung cancer (ES-SCLC) respond to first-line chemoimmunotherapy. This …